Table 3. Minor revisions and breast height reduction of immediate autologous breast reconstruction in terms of therapeutic methods and tumor stage.
| Characteristics | Minor revisions (N=61) | Reduction of breast height in early phase (N=52) | Reduction of breast height in middle phase (N=47) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No | Yes | P value | No | Yes | P value | No | Yes | P value | |||
| Radiotherapy | 0.372 | 0.7 | 0.211 | ||||||||
| No | 21 | 17 | 25 | 6 | 23 | 8 | |||||
| Yes | 10 | 13 | 16 | 5 | 9 | 7 | |||||
| Neoadjuvant chemotherapy | 0.614 | 0.278 | 0.756 | ||||||||
| No | 29 | 27 | 38 | 9 | 29 | 14 | |||||
| Yes | 2 | 3 | 3 | 2 | 3 | 1 | |||||
| Taxane chemotherapy | 0.939 | 0.556 | 0.552 | ||||||||
| No | 8 | 8 | 11 | 2 | 9 | 3 | |||||
| Yes | 23 | 22 | 30 | 9 | 23 | 12 | |||||
| Hormonal therapy | 0.198 | 0.215 | 0.706 | ||||||||
| No | 5 | 9 | 11 | 1 | 8 | 3 | |||||
| Yes | 26 | 21 | 30 | 10 | 24 | 12 | |||||
| Target therapy | 0.613 | 0.897 | 0.552 | ||||||||
| No | 22 | 23 | 29 | 8 | 24 | 10 | |||||
| Yes | 9 | 7 | 12 | 3 | 8 | 5 | |||||
| Stage | 0.717 | 0.217 | 0.465 | ||||||||
| II | 21 | 19 | 27 | 14 | 20 | 11 | |||||
| III | 10 | 11 | 5 | 6 | 12 | 4 | |||||